Application submission deadline extended to April 25, 2022 at 11:59 p.m. EST.
2022-2024 SITC-Bristol Myers Squibb Postdoctoral Cancer Immunotherapy Translational Fellowship
Term: Two-years
Amount: $200,000
This translational fellowship supports an MD, a PhD, or combined MD/PhD with a vested interest in furthering the research and translation of immunotherapeutic approaches.
2022 SITC-Amgen Cancer Immunotherapy in Hematologic Malignancies Fellowship Award
Term: One-year
Amount: $100,000
This translational fellowship supports an MD, a PhD, or combined MD/PhD with a vested interest in furthering the research and translation of immunotherapeutic approaches for the treatment of patients with hematologic malignancies.
2022 SITC-AstraZeneca Immunotherapy in Lung Cancer Clinical Fellowship
Term: One-year
Amount: $100,000
This clinical fellowship supports an MD or combined MD/PhD degree and has a vested interest in furthering the research and translation of immunotherapeutic approaches for the treatment of patients with lung cancer.
2022 SITC-Merck Cancer Immunotherapy Clinical Fellowship
Term: One-year
Amount: $100,000
This clinical fellowship supports an MD or combined MD/PhD degree and has a vested interest in furthering the research and translation of cancer immunotherapy.
2022 SITC-Genentech Women in Cancer Immunotherapy Fellowship
Term: One-year
Amount: $50,000
This fellowship supports the development of a female immunotherapy expert who has an MD, a PhD or a combined MD/PhD with a vested interest in furthering research in cancer immunotherapy. Priority will be given to female applicants who identify as part of the underrepresented populations in the biomedical sciences. US-Based applicants only.
2022 SITC-Nektar Therapeutics Cancer Immunotherapy Equity and Inclusion Fellowship
Term: One-year
Amount: $50,000
This fellowship supports Individuals from diverse backgrounds, including those from groups underrepresented in the biomedical sciences with an MD, a PhD or combined MD/PhD and a vested interest in furthering the research and translation of cancer immunotherapy.
2022 SITC-Mallinckrodt Pharmaceuticals Adverse Events in Cancer Immunotherapy Clinical Fellowship
Term: One-year
Amount: $40,000
This clinical fellowship supports an MD or combined MD/PhD with a vested interest in furthering the research of adverse events in cancer immunotherapy.
2022 SITC-Natera ctDNA in Immunotherapy Response Monitoring Fellowship and Technology Award
Term: One-year
Amount: $40,000 and access to Natera’s Signatera™ testing technology
This award supports an individual with an MD, a PhD or combined MD/PhD working in ctDNA testing for molecular residual disease. In addition to the research award, Natera will offer the selected recipient the opportunity to utilize the proprietary Signatera™ testing technology.
2022 SITC-NanoString Technologies Single Cell spatial Biology Award
Term: One-year
This technology award will enable one project to include high-plex, single cell, spatial biology using NanoString's CosMx™ Spatial Molecular Imager (SMI). Applicants will be encouraged to submit their proposals for a cancer immunotherapy project that can utilize the spatial profiling technology to advance their research.